Loading...
XSTO
ADDV B
Market cap114mUSD
Jun 11, Last price  
1.73SEK
1D
-1.70%
1Q
-14.78%
Jan 2017
-8.95%
Name

ADDvise Group AB (publ)

Chart & Performance

D1W1MN
No data to show
P/E
12.18
P/S
0.66
EPS
0.14
Div Yield, %
Shrs. gr., 5y
15.81%
Rev. gr., 5y
36.71%
Revenues
1.67b
+21.68%
33,350,00034,343,000022,289,00050,466,000100,366,000120,032,000138,068,000146,578,000195,288,000239,914,000268,219,000349,877,000358,487,000465,953,000951,521,0001,373,000,0001,670,700,000
Net income
90m
-13.04%
1,101,000-971,0000-4,771,000-275,000-3,595,000-4,566,000-4,761,000-11,098,000372,000-5,813,000-1,070,0004,059,00014,638,0002,805,00081,100,000103,500,00090,000,000
CFO
62m
-64.74%
1,412,000307,000-2,598,0001,129,0007,413,000-6,188,000-8,599,000-3,773,000-33,340,000-18,741,00060,00011,187,00057,438,00010,186,000109,876,000175,000,00061,700,000
Dividend
Apr 26, 20210.02 SEK/sh
Earnings
Jul 16, 2025

Profile

ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The company's Lab business unit designs, manufactures, and sells clean room systems and safety ventilation to laboratories, and scales to the research, industrial and grocery sectors. It is also involved in sale of equipment to laboratories, including centrifuges, water baths, and environmental chambers, and service and maintenance of scales, laboratory equipment, and storage of products. Its Healthcare business unit engages in the design, manufacture, and sale of the surgical tables, healthcare, and safety products, medtech cables, connection systems, orthopedic implants, stents for foot and ankle surgery, equipment, and software for monitoring patients, as well as operates online pharmacy. This segment also offers sale of consumable materials for healthcare, ultrasound systems, radiographic equipment, and examination tables for urology and gynecology. In addition, the company supplies laboratory furnishings and apparatus. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.
IPO date
Mar 01, 1998
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,670,700
21.68%
1,373,000
44.30%
951,521
104.21%
Cost of revenue
764,000
479,500
559,256
Unusual Expense (Income)
NOPBT
906,700
893,500
392,265
NOPBT Margin
54.27%
65.08%
41.23%
Operating Taxes
54,600
60,800
26,888
Tax Rate
6.02%
6.80%
6.85%
NOPAT
852,100
832,700
365,377
Net income
90,000
-13.04%
103,500
27.62%
81,100
2,791.27%
Dividends
Dividend yield
Proceeds from repurchase of equity
100,000
100,000
BB yield
-3.95%
-7.62%
Debt
Debt current
90,000
33,544
Long-term debt
1,614,500
820,983
Deferred revenue
300
449
Other long-term liabilities
1,831,000
288,700
227,143
Net debt
(236,500)
1,318,000
728,721
Cash flow
Cash from operating activities
61,700
175,000
109,876
CAPEX
(48,300)
(9,200)
(13,962)
Cash from investing activities
(770,100)
(684,900)
(638,587)
Cash from financing activities
556,600
783,500
303,018
FCF
840,800
831,526
313,814
Balance
Cash
355,700
386,500
111,093
Long term investments
(119,200)
14,713
Excess cash
152,965
317,850
78,230
Stockholders' equity
201,600
175,884
Invested Capital
2,666,000
2,314,000
1,393,975
ROIC
34.22%
44.91%
32.20%
ROCE
31.97%
33.29%
24.88%
EV
Common stock shares outstanding
196,710
185,803
177,457
Price
3.44
-74.78%
13.64
84.32%
7.40
-15.91%
Market cap
676,682
-73.30%
2,534,349
92.99%
1,313,183
4.26%
EV
440,182
3,852,349
2,041,904
EBITDA
906,700
1,002,200
420,197
EV/EBITDA
0.49
3.84
4.86
Interest
153,700
45,724
Interest/NOPBT
17.20%
11.66%